Johnson & Johnson Medical Devices Companies launches joint venture in KSA

The announcement was made at a press conference on Wednesday in Riyadh.
Updated 19 November 2017
0

Johnson & Johnson Medical Devices Companies launches joint venture in KSA

Johnson & Johnson Medical Devices Companies (JJMD) has announced the launch of Johnson & Johnson Medical Saudi Arabia Limited. It is a Saudi-registered legal entity resulting from a joint venture between Johnson & Johnson Middle East FZ-LLC, Abdulrehman Algosaibi and Farouk Maamoun Tamer & Co.
The launch of the Riyadh-headquartered company marks an important expansion for JJMD in the Middle East, reinforcing a strong commitment to building health care solutions in the Kingdom, sharing global expertise and innovation through professional education and developing Saudi national talent.
“Saudi Arabia is an important market and we are excited about the government’s plan to advance health care under the Saudi Vision 2030 that aims to improve quality of life and health care services. We have a deep commitment to supporting this vision by helping health care systems navigate the impact of the changing landscape, ultimately improving outcomes, increasing patient satisfaction and reducing costs in value based care,” said Michelle Brennan, company group chairman JJMD EMEA.
“The flexible new regulations introduced by the Saudi Arabian General Investment Authority have encouraged us to set up our legal presence in the Kingdom under a joint venture with our longstanding distributor partners who have strong knowledge and expertise in the Saudi market.”
The announcement was made at a press conference on Wednesday in Riyadh, held under the auspices of the Saudi Arabian General Investment Authority (SAGIA).
Johnson & Johnson Medical Saudi Arabia Limited, which also has a branch in the Red Sea port city of Jeddah, began operations in October and has started receiving orders to serve clients in the Kingdom. It launched under the leadership of General Manager Abdulaziz Al-AlSheikh with around 190 employees, including a female sales team. The new company comes to market with a Saudization rate of 25 percent and said it is committed to attracting, hiring, training and developing Saudi talent.
“We are very pleased to be strengthening our strategic partnership through this joint venture. We believe that Johnson & Johnson Medical Saudi Arabia Limited will have a positive long-term impact on health care in Saudi Arabia while also growing and enhancing the Saudi Arabian workforce,” said Magdy Saidum, director technical affairs at Abdulrehman Algosaibi, and Mohammed Tamer, group CEO and managing partner of Tamer Group.


CMRC admits first patients to new Saudi clinic

Updated 21 May 2019
0

CMRC admits first patients to new Saudi clinic

Cambridge Medical and Rehabilitation Center (CMRC), a top post-acute rehabilitation and long-term care facility in the UAE, has admitted 15 patients to its first medical facility in Saudi Arabia. 

CMRC’s new 60-bed clinic, located between Dhahran and Alkhobar, aims to help patients requiring post-acute care and rehabilitation services to make large improvements in their quality of life through multidisciplinary rehabilitative therapies including physiatry, physiotherapy, occupational therapy, speech and language therapy, and multi-sensory room sessions. 

The facility is staffed by multiple clinical experts including GPs, internal medicine consultants, pediatricians, ICU intensivists, rehabilitation consultants, psychologists and therapists, and will service patients across the eastern region of Saudi Arabia. 

It follows the same clinical procedures and protocols successfully implemented in facilities in the UAE, similarly benefiting from the center’s international partnership with the Spaulding Rehabilitation Network, a teaching affiliate of Harvard Medical School, and accreditations from Joint Commission International, CARF and Planetree.

FASTFACT

 

CMRC, a portfolio company of health care specialist investor TVM Capital Healthcare, also operates facilities in Abu Dhabi and Al-Ain in the UAE.

CMRC Group CEO Dr. Howard S. Podolsky said: “We expand into countries where there is notable demand for post-acute care and rehabilitation services. Like many countries around the world, Saudi Arabia is experiencing a rise in the incidence of non-communicable diseases, birth defects, and life-threatening injuries. Our new facility brings our world-class medical treatment, care, and rehabilitation therapies to the Kingdom through a truly patient-centric approach.”

He added: “We look forward to helping families in the region improve their quality of life and using our international expertise and specialized workforce to support the government of Saudi Arabia’s focus on health care development, as part of Saudi Vision 2030.” 

CMRC, a portfolio company of health care specialist investor TVM Capital Healthcare, also operates facilities in Abu Dhabi and Al-Ain in the UAE.

Dr. Helmut Schuehsler, CEO of TVM Capital Healthcare and board member of CMRC, said: “We believe that private equity investment should be a force for good, and that by working in health care, we have a real opportunity to make a difference to patients’ lives. Therefore, we conceptualized and invested in CMRC in the UAE to cater to those in need of post-acute care and an elevated level of rehabilitation. CMRC grew to be the leading post-acute care and rehabilitation provider in the UAE. We are very happy to bring the offer to the people of Saudi Arabia now.”

CMRC offers both inpatient services at its medical centers and outpatient therapy, where patients follow a rehabilitation program after discharge. The company employs more than 500 staff members across all facilities.